![Sofia Ioannidou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sofia Ioannidou
Inversor de Capital Privado en
Andera Partners SCA
.
Perfil
Sofia Ioannidou is a Partner at Andera Partners SCA since 2019, with employment at the firm starting in 2009.
Former positions include Director at Cellnovo Group SA, Director at TRiCares SAS, Independent Director at LogicBio Therapeutics, Inc. from 2017 to 2019, and Director at Avalyn Pharma, Inc. Education includes undergraduate and graduate degrees from the University of Oxford conferred in 2000, and a doctorate from University College London conferred in 2004.
Cargos activos de Sofia Ioannidou
| Empresas | Cargo | Inicio |
|---|---|---|
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Inversor de Capital Privado | 01/03/2013 |
Antiguos cargos conocidos de Sofia Ioannidou.
| Empresas | Cargo | Fin |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 25/06/2019 |
| AVALYN PHARMA INC. | Director/Miembro de la Junta | - |
TRiCares SAS
 TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Director/Miembro de la Junta | - |
| CELLNOVO | Director/Miembro de la Junta | - |
Formación de Sofia Ioannidou.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
97
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides debt financing through mezzanine, growth capital but also financing for later stage, LBO, MBO and buyout. The firm seeks for minority or majority stakes and also makes co-investments. | Finance |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Manufactures medical device that manages diabetic control | Health Technology |
TRiCares SAS
TRiCares SAS Medical SpecialtiesHealth Technology Commercializes medical device | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
- Bolsa de valores
- Insiders
- Sofia Ioannidou
